AU2001288695A1 - Flavoring systems for pharmaceutical compositions and methods of making such compositions - Google Patents

Flavoring systems for pharmaceutical compositions and methods of making such compositions

Info

Publication number
AU2001288695A1
AU2001288695A1 AU2001288695A AU8869501A AU2001288695A1 AU 2001288695 A1 AU2001288695 A1 AU 2001288695A1 AU 2001288695 A AU2001288695 A AU 2001288695A AU 8869501 A AU8869501 A AU 8869501A AU 2001288695 A1 AU2001288695 A1 AU 2001288695A1
Authority
AU
Australia
Prior art keywords
compositions
making
methods
pharmaceutical compositions
flavoring systems
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001288695A
Inventor
Laman Alani
Donald P. Gauwitz
Soumojeet Ghosh
Dilip Kaul
John M. Lipari
Kennan C Marsh
Vanik D. Petrossian
Richard H. Whelan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Laboratories
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Laboratories filed Critical Abbott Laboratories
Publication of AU2001288695A1 publication Critical patent/AU2001288695A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/426—1,3-Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Fats And Perfumes (AREA)
AU2001288695A 2000-09-05 2001-09-04 Flavoring systems for pharmaceutical compositions and methods of making such compositions Abandoned AU2001288695A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US65519200A 2000-09-05 2000-09-05
US09655192 2000-09-05
PCT/US2001/027415 WO2002020057A2 (en) 2000-09-05 2001-09-04 Flavoring systems for pharmaceutical compositions and methods of making such compositions

Publications (1)

Publication Number Publication Date
AU2001288695A1 true AU2001288695A1 (en) 2002-03-22

Family

ID=24627898

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001288695A Abandoned AU2001288695A1 (en) 2000-09-05 2001-09-04 Flavoring systems for pharmaceutical compositions and methods of making such compositions

Country Status (10)

Country Link
EP (1) EP1315487A2 (en)
JP (1) JP2004522698A (en)
AR (1) AR030715A1 (en)
AU (1) AU2001288695A1 (en)
BR (1) BR0108433A (en)
CA (1) CA2417258A1 (en)
MX (1) MXPA03001952A (en)
PE (1) PE20020373A1 (en)
UY (1) UY26925A1 (en)
WO (1) WO2002020057A2 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1175205B1 (en) 1999-11-12 2006-06-14 Abbott Laboratories Solid dispersion comprising ritonavir, fenofibrate or griseofulvin
BR0316318A (en) * 2002-11-22 2005-09-27 Firmenich & Cie Oral composition, and, method of masking the salty taste of a salt in an oral composition
US8025899B2 (en) 2003-08-28 2011-09-27 Abbott Laboratories Solid pharmaceutical dosage form
GB2423711B (en) * 2005-10-24 2007-02-14 Fortune Apex Dev Ltd Method for preparing a pharmaceutical composition with enhanced mucoadhesion
TW201340998A (en) * 2012-02-29 2013-10-16 Takeda Pharmaceutical Oral preparation
US8771651B2 (en) * 2012-09-10 2014-07-08 Johnson & Johnson Consumer Companies, Inc. Mouth rinses and tooth sensitivity treatment compositions

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL111991A (en) * 1994-01-28 2000-07-26 Abbott Lab Liquid pharmaceutical composition of HIV protease inhibitors in organic solvent
AU3146997A (en) * 1996-06-03 1998-01-05 Merck & Co., Inc. Pediatric formulation for hiv protease inhibitors

Also Published As

Publication number Publication date
EP1315487A2 (en) 2003-06-04
UY26925A1 (en) 2002-04-26
AR030715A1 (en) 2003-09-03
MXPA03001952A (en) 2003-09-10
PE20020373A1 (en) 2002-05-13
JP2004522698A (en) 2004-07-29
CA2417258A1 (en) 2002-03-14
WO2002020057A2 (en) 2002-03-14
WO2002020057A3 (en) 2002-05-10
BR0108433A (en) 2006-06-06

Similar Documents

Publication Publication Date Title
AU2002345970A1 (en) Stabilized compositions and processes of their preparation
AU2001294808A1 (en) Catecholamine pharmaceutical compositions and methods
AU2002363236A1 (en) Compounds, pharmaceutical compositions and methods of use therefor
AU2002220825A1 (en) Oral pharmaceutical compositions containing cyclodextrins as taste masking agent
AU2002225894A1 (en) Methods and compositions for the control of coccidiosis
AU5565099A (en) Pharmaceutical compositions and methods for use
AU2002216346A1 (en) Cabergoline pharmaceutical compositions and methods of use thereof
AU2001288395A1 (en) Method for enhanced delivery of oxybutynin and compositions thereof
AU2001230898A1 (en) Formulations and methods for administration of pharmacologically or biologicallyactive compounds
AU2002351388A1 (en) Methods and compositions for controlled release of drugs
AU2001288938A1 (en) Edible candy compositions and methods of using the same
AU3560601A (en) Novel isoquinoline derivatives, preparation method and pharmaceutical compositions containing them
AU2001277889A1 (en) Veneer-based product and method of manufacture
AU2001288695A1 (en) Flavoring systems for pharmaceutical compositions and methods of making such compositions
AU2002360117A1 (en) Aralkyl-tetrahydro-pyridines, their preparation and pharmaceutical compositions containing same
AU2001255754A1 (en) Methods and compositions for the manufacture of molecular beacons
AU2001252711A1 (en) Aqueous-prodrug compound comprising moiety of paclitxel or derivatives thereof, method of preparing same and pharmaceutical composition comprising same
AU2002341555A1 (en) Levothyroxine pharmaceutical compositions, methods of making and methods of administration
AU2002303552A1 (en) Methods and compositions for prevention of angioproliferation
AU2002334123A1 (en) Anaesthetic compositions and method for their administration
AU4876701A (en) Peptide derivatives and medicinal compositions
AU2002212327A1 (en) Pharmaceutical preparation comprised of milk-thistle and terpenes
AU2002246658A1 (en) Benzoylalkylindolepyridinium compounds and pharmaceutical compositions comprising such compounds
AU2001262928A1 (en) Pharmaceutical compositions and their use
AU2001253336A1 (en) Method 0f administration of paclitaxel-plasma protein formulation